{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:10Z","timestamp":1787041630080,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011785","name":"Guangxi Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119124","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:12:09Z","timestamp":1783177929000},"page":"119124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rational design and synthesis of TBC1D2 inhibitors: Augmenting autophagy to improve sorafenib sensitivity in hepatocellular carcinoma"],"prefix":"10.1016","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6790-8633","authenticated-orcid":false,"given":"Keyan","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2655-0724","authenticated-orcid":false,"given":"Lisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119124_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving global etiology of hepatocellular carcinoma (HCC): insights and trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.ejmech.2026.119124_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107526","article-title":"Artesunate: a potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma","volume":"210","author":"Liu","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.119124_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12935-025-03821-y","article-title":"Hepatocellular carcinoma drug resistance models","volume":"25","author":"Xie","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2026.119124_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2023.0125","article-title":"Recent advances in the management of hepatocellular carcinoma","volume":"30","author":"Sankar","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.ejmech.2026.119124_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12575-025-00281-6","article-title":"Mechanisms of drug resistance in hepatocellular carcinoma","volume":"27","author":"Zou","year":"2025","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.ejmech.2026.119124_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189310","article-title":"Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119124_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-024-01647-1","article-title":"Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2026.119124_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/md23080297","article-title":"An oncolytic Vaccinia virus expressing Aphrocallistes Vastus lectin modulates hepatocellular carcinoma metabolism via ACSS2\/TFEB-Mediated autophagy and lipid accumulation","author":"Wang","year":"2025","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2026.119124_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41420-025-02667-7","article-title":"Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression","volume":"11","author":"Goyal","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejmech.2026.119124_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216744","article-title":"Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: emphasis on cell death mechanism crosstalk","volume":"588","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.119124_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10565-025-10008-8","article-title":"CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancer","volume":"41","author":"Xu","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejmech.2026.119124_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41419-024-06955-5","article-title":"Autophagy modulation attenuates sorafenib resistance in HCC induced in rats","volume":"15","author":"Elleithi","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119124_bib13","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41388-025-03371-7","article-title":"Syntaxin-6 mediated autophagy confers lenvatinib resistance in hepatocellular carcinoma","volume":"44","author":"Zhang","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.119124_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s10020-025-01263-w","article-title":"Overexpression of c-Myc triggers p62 aggregation-mediated mitochondrial mitophagy in cabozantinib resistance of hepatocellular carcinoma","volume":"31","author":"Yang","year":"2025","journal-title":"Mol. Med. (London, U. K.)"},{"key":"10.1016\/j.ejmech.2026.119124_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123966","article-title":"Autophagy regulation in ovarian cancer chemoresistance: molecular mechanisms and emerging frontiers","volume":"380","author":"Yang","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2026.119124_bib16","article-title":"Autophagy in doxorubicin resistance: basic concepts, therapeutic perspectives and clinical translation","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119124_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10565-024-09979-x","article-title":"Targeting p38\u03b3 synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma","volume":"41","author":"Huang","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejmech.2026.119124_bib18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1158\/1535-7163.MCT-13-1043","article-title":"Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to Autophagic cell death in hepatocellular carcinoma","volume":"13","author":"Zhai","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2026.119124_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157603","article-title":"Lasiodin sensitizes hepatocellular carcinoma cancer to sorafenib via SNARE complex disruption","volume":"149","author":"Lian","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2026.119124_bib20","first-page":"583","article-title":"Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway, Cell Commun","volume":"22","author":"Qian","year":"2024","journal-title":"Signal"},{"key":"10.1016\/j.ejmech.2026.119124_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115952","article-title":"A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses","volume":"263","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119124_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116688","article-title":"Autophagy modulation in cancer therapy: challenges coexist with opportunities","volume":"276","author":"Wu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119124_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.devcel.2013.03.005","article-title":"The TBC\/RabGAP armus coordinates Rac1 and Rab7 functions during autophagy","volume":"25","author":"Carroll","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejmech.2026.119124_bib24","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1242\/jcs.192260","article-title":"Vps34 regulates Rab7 and late endocytic trafficking through recruitment of the GTPase-activating protein Armus","volume":"129","author":"Jaber","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2026.119124_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1013566","article-title":"OCIAD2 as a novel prognostic and therapeutic biomarker for pancreatic cancer: a study based on transcriptomic signature and bioinformatics analysis","volume":"21","author":"Cui","year":"2025","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2026.119124_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12885-023-10532-y","article-title":"A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC","volume":"23","author":"Ding","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejmech.2026.119124_bib27","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1158\/0008-5472.CAN-17-1143","article-title":"Super-Enhancers promote transcriptional dysregulation in nasopharyngeal carcinoma","volume":"77","author":"Yuan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119124_bib28","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.7150\/jca.51551","article-title":"Identification of potential BRAF inhibitor joint therapy targets in PTC based on WGCAN and DCGA","volume":"12","author":"Han","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119124_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10565-024-09866-5","article-title":"Function and regulation of Rab GTPases in cancers","volume":"40","author":"Xu","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejmech.2026.119124_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54324-9","article-title":"Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3\u03b2\/\u03b2-Catenin\/MITF-axis","volume":"15","author":"Abrahamian","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119124_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk9944","article-title":"A trafficking regulatory subnetwork governs \u03b1V\u03b26 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance","volume":"10","author":"Maldonado","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119124_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106862","article-title":"Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma","volume":"158","author":"Liu","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejmech.2026.119124_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/biof.70006","article-title":"Investigating the impact of Ras-related protein RAB7A on colon adenocarcinoma behavior and its clinical significance","volume":"51","author":"Shan","year":"2025","journal-title":"Biofactors"},{"key":"10.1016\/j.ejmech.2026.119124_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118978","article-title":"Novel autophagy-promoted cancer therapy: discovery of matrine-based selective TBC1D2 inhibitors by drug-target complex purification","volume":"315","author":"Han","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119124_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2019.08.002","article-title":"Liver X receptor agonism sensitizes a subset of hepatocellular carcinoma to sorafenib by dual-inhibiting MET and EGFR","volume":"22","author":"Shao","year":"2020","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2026.119124_bib36","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.omtn.2019.04.008","article-title":"FOXM1-Mediated LINC-ROR regulates the proliferation and sensitivity to sorafenib in hepatocellular carcinoma","volume":"16","author":"Zhi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2026.119124_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00018-025-05801-x","article-title":"Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation","volume":"82","author":"He","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2026.119124_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12951-025-03134-2","article-title":"Recent advances of anti-tumor nano-strategies via overturning pH gradient: alkalization and acidification","volume":"23","author":"Gong","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2026.119124_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113328","article-title":"Lysosomal sequestration of weak base drugs, lysosomal biogenesis, and cell cycle alteration","volume":"153","author":"Mlejnek","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:00:27Z","timestamp":1787040027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":39,"alternative-id":["S0223523426005696"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119124","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design and synthesis of TBC1D2 inhibitors: Augmenting autophagy to improve sorafenib sensitivity in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119124"}}